NK 细胞在子宫内膜癌肿瘤免疫逃逸与免疫治疗耐药交界处的作用

Natural killer cells at the interface of tumor immune escape and immunotherapy resistance in endometrial cancer.

ROBO1 CAR-NK92 细胞中 Cbl-b 敲除增强其抗肿瘤疗效

Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy.

IL-15 增强抗核心 1 O-聚糖单克隆抗体 NEO-201 对人子宫内膜癌与卵巢癌的临床前疗效

IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer.

IL-15 增强 NEO-201 疗效的能力，以 NK 细胞作为效应细胞，支持将 NEO-201 和 IL-15 与 NK 细胞疗法（即分泌 IL-15 的 CAR-NK 细胞，具有更长的 IL-15 体内半衰期和更强的 NK 活性）联合用于治疗表达 NEO-201 所识别 O-聚糖的妇科癌症的假设。

CAR-NK 细胞用于妇科肿瘤：免疫微环境重塑与免疫治疗策略

CAR-NK cell for gynecological cancers: immune microenvironment remodeling and immunotherapeutic strategies.